Eyecuracy Information

Eyecuracy is developing the first objective, AI-powered diagnostic platform for Binocular Vision Disorders (BVD) — a condition affecting 60 million Americans, fewer than 1 in 10 of whom are ever diagnosed. Our calibration-free limbus tracking technology delivers 0.4° accuracy — 5× more precise than the current standard — enabling fast, objective diagnostics in-clinic and continuous monitoring at home, without patient self-reports or specialist training. The same platform creates a foundation for neurological disease monitoring via eye-movement biomarkers, with a roadmap into Parkinson's disease, Multiple Sclerosis, and concussions. Traction: 5 pilot studies at UC Berkeley School of Optometry and University of Regensburg Eye Clinic 8 patents granted (USA, Europe, China, Japan, Taiwan, Israel) Signed NRE & Royalties agreement with a top-5 neuro-surgery equipment provider Contact: albert.k@eyecuracy.com